TrialThe Journal of infectious diseases2022

Nonadherence to Ledipasvir/Sofosbuvir Did Not Predict Sustained Virologic Response in a Randomized Controlled Trial of Human Immunodeficiency Virus/Hepatitis C Virus Coinfected Persons Who Use Drugs.

Kathleen M Ward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.